Centessa Pharmaceuticals PLC (CNTA)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | ||||||
| Total Assets | 479.36M | 444.31M | 403.86M | 392.92M | 377.36M | 360.25M | 328.17M | 398.85M |
| Total Current Assets | 476.99M | 437.75M | 384.33M | 350.41M | 332.45M | 315.09M | 284.48M | 355.5M |
| Cash and Equivalents | 444.84M | 393.64M | 259.99M | 145.22M | 171.5M | 128.03M | 118.22M | 127.37M |
| Total Non-Current Assets | 2.92M | 6.56M | 7.26M | 30.17M | 33.88M | 34.28M | 32M | 32.78M |
| Total Liabilities | 106.43M | 108.14M | 110.6M | 116.32M | 117.97M | 124M | 113.01M | 111.88M |
| Total Current Liabilities | 38.19M | 38.34M | 29.69M | 33.87M | 34.95M | 39.39M | 27.44M | 26.76M |
| Total Non-Current Liabilities | 136.44M | 139.6M | 152.51M | 155.75M | 157.02M | 160.32M | 162.37M | 161.63M |
| Common Equity | 263k | 265k | 265k | 266k | 271k | 273k | 277k | 309k |
| Retained Earnings | -560.38M | -601.86M | -652.57M | -677.46M | -716.11M | -752.95M | -790.99M | -834.81M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |
| Total Assets | 629.64M | 444.31M | 360.25M |
| Total Current Assets | 628.77M | 437.75M | 315.09M |
| Cash and Equivalents | 595.08M | 393.64M | 128.03M |
| Total Non-Current Assets | 491.55M | 336.17M | 236.24M |
| Total Liabilities | 138.08M | 108.14M | 124M |
| Total Current Liabilities | 24.64M | 38.34M | 39.39M |
| Total Non-Current Liabilities | 189.14M | 139.6M | 160.32M |
| Total Equity | 491.55M | 336.17M | 236.24M |
| Common Equity | 252k | 265k | 273k |
| Retained Earnings | -385.65M | -601.86M | -752.95M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
